ACTIVATION AND TRIGGERING OF CYTOXIC CELLS

细胞毒性细胞的激活和触发

基本信息

  • 批准号:
    6100949
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

We have previously used redirected cytotoxicity experiments to study and define triggering molecules on cytotoxic cells. While the TcR and FcR are the principal triggering molecules on human leukocytes, we have recently found that adhesion molecules can also serve as cytotoxic triggers on some cell types. In this project we have used redirected lysis to identify several cytotoxic triggering molecules on human NK cells. We show that upon activation with IL-2, CD38, CD44, CD56, and CD69 acquire triggering function in NK cells but not in CTL. By contrast, MHC-1, B2 integrins, and NKR-P1A failed to trigger lysis. Effector:target conjugates were induced by mAbs to both triggering and non-triggering receptors, indicating that conjugate formation per se was not a lytic signal. Actinomycin D blocked the induction of triggering capacity of CD38, CD44, CD56, and CD69, but failed to abolish FcRIIIA- mediated lysis or the surface expression of CD38, CD44 and CD69. We suggest that IL-2 stimulates the de novo expression of proteins that serve as intermediaries between several NK surface receptors and the lytic machinery. Such linker proteins could control the target cell specificty of natural cytotoxicity. Effector cells gain cytotoxic capacity upon activation, but in a number of conditions the gain of killing function is suppressed. To investigate the basis of immunosuppression, lymphocytes were screened for abnormalities in the expression of signal transducing proteins known to be involved in the regulation of cellular immunity. Cells from immunosuppressed tumor bearing mice and from HIV infected patients were used in these experiments. In both cases, a selective loss in STAT5 protein expression was observed. Since STAT5 is an essential component in the signalling pathway of several cytokines that are required for immune function, it is possible that the downregulation of this transcription factor plays an important role in the observed suppression of immune function.
我们以前使用重定向细胞毒性实验来研究和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

D M SEGAL其他文献

D M SEGAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('D M SEGAL', 18)}}的其他基金

TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    3813455
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ACTIVATION AND TRIGGERING OF CYTOXIC CELLS
细胞毒性细胞的激活和触发
  • 批准号:
    2463758
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ACTIVATION AND TRIGGERING OF CYTOXIC CELLS
细胞毒性细胞的激活和触发
  • 批准号:
    6161049
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNOLOGICALLY RELEVANT CELL SURFACE PHENOMENA
免疫相关的细胞表面现象
  • 批准号:
    3962941
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    3796538
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    3752089
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    3774386
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    3808592
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES OF IMMUNOLOGICALLY RELEVANT CELL SURFACE PHENOMENA
免疫相关细胞表面现象的研究
  • 批准号:
    4691756
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGETED CELLULAR CYTOTOXICITY
靶向细胞毒性
  • 批准号:
    5201004
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Inhibition of tumor growth, invasion, and metastasis by targeting CD44 molecule
靶向CD44分子抑制肿瘤生长、侵袭和转移
  • 批准号:
    13557094
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
  • 批准号:
    2770673
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
  • 批准号:
    2471152
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Study on CD44 molecule in follicular lymphoma
滤泡性淋巴瘤中CD44分子的研究
  • 批准号:
    07670232
  • 财政年份:
    1995
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了